{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:50:09Z","timestamp":1793379009598,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T00:00:00Z","timestamp":1316217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00228-011-1122-4","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T13:09:13Z","timestamp":1316178553000},"page":"301-309","source":"Crossref","is-referenced-by-count":109,"title":["Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning"],"prefix":"10.1007","volume":"68","author":[{"given":"Margareeta","family":"H\u00e4kkinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Launiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkki","family":"Vuori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Ojanper\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,17]]},"reference":[{"key":"1122_CR1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","volume":"35","author":"DR Jasinski","year":"1978","unstructured":"Jasinski DR, Pevnick JS, Griffith JD (1978) Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch Gen Psychiatry 35:501\u2013516","journal-title":"Arch Gen Psychiatry"},{"key":"1122_CR2","first-page":"123","volume":"8","author":"JW Lewis","year":"1973","unstructured":"Lewis JW (1973) Ring C-bridged derivatives of thebaine and oripavine. Adv Biochem Psychopharmacol 8:123\u2013136","journal-title":"Adv Biochem Psychopharmacol"},{"key":"1122_CR3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1476-5381.1977.tb07533.x","volume":"60","author":"A Cowan","year":"1977","unstructured":"Cowan A, Doxey JC, Harry EJ (1977) The animal pharmacology of buprenorphine, an oripavine analgesic agent. Br J Pharmacol 60:547\u2013554","journal-title":"Br J Pharmacol"},{"key":"1122_CR4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","volume":"60","author":"A Cowan","year":"1977","unstructured":"Cowan A, Lewis JW, Macfarlane IR (1977) Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 60:537\u2013545","journal-title":"Br J Pharmacol"},{"key":"1122_CR5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","volume":"197","author":"WR Martin","year":"1976","unstructured":"Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517\u2013532","journal-title":"J Pharmacol Exp Ther"},{"key":"1122_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-2999(88)90149-5","volume":"156","author":"SS Negus","year":"1988","unstructured":"Negus SS, Dykstra LA (1988) Kappa antagonist properties of buprenorphine in the shock titration procedure. Eur J Pharmacol 156:77\u201386","journal-title":"Eur J Pharmacol"},{"key":"1122_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0014-2999(88)90543-2","volume":"151","author":"JD Leander","year":"1988","unstructured":"Leander JD (1988) Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice. Eur J Pharmacol 151:457\u2013461","journal-title":"Eur J Pharmacol"},{"key":"1122_CR8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.7352279","volume":"207","author":"NK Mello","year":"1980","unstructured":"Mello NK, Mendelson JH (1980) Buprenorphine suppresses heroin use by heroin addicts. Science 207:657\u2013659","journal-title":"Science"},{"key":"1122_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/00498258109045291","volume":"11","author":"D Brewster","year":"1981","unstructured":"Brewster D, Humphrey MJ, McLeavy MA (1981) Biliary excretion, metabolism and enterohepatic circulation of buprenorphine. Xenobiotica 11:189\u2013196","journal-title":"Xenobiotica"},{"key":"1122_CR10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0090-9556(25)07765-7","volume":"12","author":"EJ Cone","year":"1984","unstructured":"Cone EJ, Gorodetzky CW, Yousefnejad D, Buchwald WF, Johnson RE (1984) The metabolism and excretion of buprenorphine in humans. Drug Metab Dispos 12:577\u2013581","journal-title":"Drug Metab Dispos"},{"key":"1122_CR11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3565(25)24425-1","volume":"272","author":"M Ohtani","year":"1995","unstructured":"Ohtani M, Kotaki H, Sawada Y, Iga T (1995) Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 272:505\u2013510","journal-title":"J Pharmacol Exp Ther"},{"key":"1122_CR12","first-page":"818","volume":"26","author":"K Kobayashi","year":"1998","unstructured":"Kobayashi K, Yamamoto T, Chiba K, Tani M, Shimada N, Ishizaki T, Kuroiwa Y (1998) Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4. Drug Metab Dispos 26:818\u2013821","journal-title":"Drug Metab Dispos"},{"key":"1122_CR13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","volume":"44","author":"A Elkader","year":"2005","unstructured":"Elkader A, Sproule B (2005) Buprenorphine: Clinical pharmacokinetics in the treatment of opioid dependence. Clin Pharmacokinet 44:661\u2013680","journal-title":"Clin Pharmacokinet"},{"key":"1122_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.forsciint.2005.09.004","volume":"160","author":"A Steentoft","year":"2006","unstructured":"Steentoft A, Teige B, Holmgren P, Vuori E, Kristinsson J, Hansen AC, Ceder G, Wethe G, Rollmann D (2006) Fatal poisoning in Nordic drug addicts in 2002. Forensic Sci Int 160:148\u2013156","journal-title":"Forensic Sci Int"},{"key":"1122_CR15","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2009) Drug situation\u2014Finland 2009. National Report to the EMCDDA. EMCDDA, Lisbon"},{"key":"1122_CR16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.forsciint.2010.10.001","volume":"207","author":"KW Simonsen","year":"2011","unstructured":"Simonsen KW, Normann PT, Ceder G, Vuori E, Thordardottir S, Thelander G, Hansen AC, Teige B, Rollmann D (2011) Fatal poisoning in drug addicts in the Nordic countries in 2007. Forensic Sci Int 207:170\u2013176","journal-title":"Forensic Sci Int"},{"key":"1122_CR17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/08039488.2010.531762","volume":"65","author":"M Aalto","year":"2011","unstructured":"Aalto M, Visap\u00e4\u00e4 J, Halme JT, Fabritius C, Salaspuro M (2011) Effectiveness of buprenorphine maintenance treatment as compared to a syringe exchange program among buprenorphine misusing opioid-dependent patients. Nord J Psychiatry 65:238\u2013243","journal-title":"Nord J Psychiatry"},{"key":"1122_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1521-0391.2009.00007.x","volume":"19","author":"N Lintzeris","year":"2009","unstructured":"Lintzeris N, Nielsen S (2009) Benzodiazepines, methadone and buprenorphine: interactions and clinical management. Am J Addiction 19:59\u201372","journal-title":"Am J Addiction"},{"key":"1122_CR19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1360-0443.1999.9479612.x","volume":"94","author":"JM White","year":"1999","unstructured":"White JM, Irvine RJ (1999) Mechanisms of fatal opioid overdose. Addiction 94:961\u2013972","journal-title":"Addiction"},{"key":"1122_CR20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0376-8716(00)00128-9","volume":"61","author":"J Gerostamoulos","year":"2001","unstructured":"Gerostamoulos J, Staikos V, Drummer OH (2001) Heroin-related deaths in Victoria: a review of cases for 1997 and 1998. Drug Alcohol Depend 61:123\u2013127","journal-title":"Drug Alcohol Depend"},{"key":"1122_CR21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1467-842X.2002.tb00185.x","volume":"26","author":"JR Caplehorn","year":"2002","unstructured":"Caplehorn JR, Drummer OH (2002) Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines. Aust NZ J Publ Heal 26:358\u2013362","journal-title":"Aust NZ J Publ Heal"},{"key":"1122_CR22","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1365-2044.1983.tb12045.x","volume":"38","author":"MH Faroqui","year":"1983","unstructured":"Faroqui MH, Cole M, Curran J (1983) Buprenorphine, benzodiazepines and respiratory depression. Anaesthesia 38:1002\u20131003","journal-title":"Anaesthesia"},{"key":"1122_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2044.1983.tb13941.x","volume":"38","author":"DP Papworth","year":"1983","unstructured":"Papworth DP (1983) High dose buprenorphine for postoperative analgesia. Anaesthesia 38:163","journal-title":"Anaesthesia"},{"key":"1122_CR24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jat\/22.6.430","volume":"22","author":"A Tracqui","year":"1998","unstructured":"Tracqui A, Kintz P, Ludes B (1998) Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J Anal Toxicol 22:430\u2013434","journal-title":"J Anal Toxicol"},{"key":"1122_CR25","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1046\/j.1360-0443.1998.93913859.x","volume":"93","author":"M Reynaud","year":"1998","unstructured":"Reynaud M, Petit G, Potard D, Courty P (1998) Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction 93:1385\u20131392","journal-title":"Addiction"},{"key":"1122_CR26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0379-0738(01)00454-6","volume":"121","author":"P Kintz","year":"2001","unstructured":"Kintz P (2001) Deaths involving buprenorphine: a compendium of French cases. Forensic Sci Int 121:65\u201369","journal-title":"Forensic Sci Int"},{"key":"1122_CR27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0009-9120(02)00304-1","volume":"35","author":"P Kintz","year":"2002","unstructured":"Kintz P (2002) A new series of 13 buprenorphine-related deaths. Clin Biochem 35:513\u2013516","journal-title":"Clin Biochem"},{"key":"1122_CR28","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1360-0443.2004.00790.x","volume":"99","author":"S Pirnay","year":"2004","unstructured":"Pirnay S, Borron SW, Giudicelli CP, Tourneau J, Baud FJ, Ricordel I (2004) A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction 99:978\u2013988","journal-title":"Addiction"},{"key":"1122_CR29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.forsciint.2006.03.037","volume":"162","author":"SH Lai","year":"2006","unstructured":"Lai SH, Yao YJ, Lo DST (2006) A survey of buprenorphine related deaths in Singapore. Forensic Sci Int 162:80\u201386","journal-title":"Forensic Sci Int"},{"key":"1122_CR30","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.forsciint.2010.05.015","volume":"204","author":"O Ferrant","year":"2011","unstructured":"Ferrant O, Papin F, Clin B, Lacroix C, Saussereau E, Remou\u00e9 J, Goull\u00e9 J (2011) Fatal poisoning due to snorting buprenorphine and alcohol consumption. Forensic Sci Int 204:e8\u2013e11","journal-title":"Forensic Sci Int"},{"key":"1122_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2005.01.004","volume":"79","author":"S Nielsen","year":"2005","unstructured":"Nielsen S, Taylor DA (2005) The effect of buprenorphine and benzodiazepines on respiration in the rat. Drug Alcohol Depend 79:95\u2013101","journal-title":"Drug Alcohol Depend"},{"key":"1122_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drugalcdep.2007.05.019","volume":"91","author":"N Lintzeris","year":"2007","unstructured":"Lintzeris N, Mitchell TB, Bond AJ, Nestor L, Strang J (2007) Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients. Drug Alcohol Depend 91:187\u2013194","journal-title":"Drug Alcohol Depend"},{"key":"1122_CR33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/ip.2006.012922","volume":"13","author":"P Lunetta","year":"2007","unstructured":"Lunetta P, Lounamaa A, Sihvonen S (2007) Surveillance of injury-related deaths: medicolegal autopsy rates and trends in Finland. Inj Prev 13:282\u2013284","journal-title":"Inj Prev"},{"key":"1122_CR34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00414-008-0261-3","volume":"123","author":"T Launiainen","year":"2009","unstructured":"Launiainen T, Vuori E, Ojanper\u00e4 I (2009) Prevalence of adverse drug combinations in a large post-mortem toxicology database. Int J Legal Med 123:109\u2013115","journal-title":"Int J Legal Med"},{"key":"1122_CR35","volume-title":"Disposition of toxic drugs and chemicals in man","author":"RC Baselt","year":"2008","unstructured":"Baselt RC (2008) Disposition of toxic drugs and chemicals in man. Biomedical Publications, Foster City"},{"key":"1122_CR36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1520\/JFS14071J","volume":"42","author":"H Druid","year":"1997","unstructured":"Druid H, Holmgren P (1997) A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci 42:79\u201387","journal-title":"J Forensic Sci"},{"key":"1122_CR37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.forsciint.2009.01.013","volume":"186","author":"M Gergov","year":"2009","unstructured":"Gergov M, Nokua P, Vuori E, Ojanper\u00e4 I (2009) Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography\u2013tandem mass spectrometry. Forensic Sci Int 186:36\u201343","journal-title":"Forensic Sci Int."},{"key":"1122_CR38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jat\/27.4.226","volume":"27","author":"A Pelander","year":"2003","unstructured":"Pelander A, Ojanper\u00e4 I, Sistonen J, Rasanen I, Vuori E (2003) Screening for basic drugs in 2-mL urine samples by dual-plate overpressured layer chromatography and comparison with gas chromatography-mass spectrometry. J Anal Toxicol 27:226\u2013232","journal-title":"J Anal Toxicol"},{"key":"1122_CR39","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1021\/ac030162o","volume":"75","author":"A Pelander","year":"2003","unstructured":"Pelander A, Ojanper\u00e4 I, Laks S, Rasanen I, Vuori E (2003) Toxicological screening with formula-based metabolite identification by liquid chromatography\/time-of-flight mass spectrometry. Anal Chem 75:5710\u20135718","journal-title":"Anal Chem"},{"key":"1122_CR40","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/rcm.2429","volume":"20","author":"S Ojanper\u00e4","year":"2006","unstructured":"Ojanper\u00e4 S, Pelander A, Pelzing M, Krebs I, Vuori E, Ojanper\u00e4 I (2006) Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography\/time-of-flight mass spectrometry. Rapid Commun Mass Sp 20:1161\u20131167","journal-title":"Rapid Commun Mass Sp"},{"key":"1122_CR41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jat\/15.4.204","volume":"15","author":"I Ojanper\u00e4","year":"1991","unstructured":"Ojanper\u00e4 I, Rasanen I, Vuori E (1991) Automated quantitative screening for acidic and neutral drugs in whole blood by dual-column capillary gas chromatography. J Anal Toxicol 15:204\u2013208","journal-title":"J Anal Toxicol"},{"key":"1122_CR42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jat\/24.1.46","volume":"24","author":"I Rasanen","year":"2000","unstructured":"Rasanen I, Ojanpera I, Vuori E (2000) Quantitative screening for benzodiazepines in blood by dual-column gas chromatography and comparison of the results with urine immunoassay. J Anal Toxicol 24:46\u201353","journal-title":"J Anal Toxicol"},{"key":"1122_CR43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1570-0232(02)01012-7","volume":"788","author":"I Rasanen","year":"2003","unstructured":"Rasanen I, Kontinen I, Nokua J, Ojanper\u00e4 I, Vuori E (2003) Precise gas chromatography with retention time locking in comprehensive toxicological screening for drugs in blood. J Chromatogr B 788:243\u2013250","journal-title":"J Chromatogr B"},{"key":"1122_CR44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/clpt.1980.219","volume":"28","author":"RES Bullingham","year":"1980","unstructured":"Bullingham RES, McQuay HJ, Moore RA, Bennett MRD (1980) Buprenorphine kinetics. Clin Pharmacol Ther 28:667\u2013672","journal-title":"Clin Pharmacol Ther"},{"key":"1122_CR45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.forsciint.2011.01.011","volume":"209","author":"T Seld\u00e9n","year":"2011","unstructured":"Seld\u00e9n T, Roman M, Druid H, Kronstrand R (2011) LC\u2013MS\u2013MS analysis of buprenorphine and norbuprenorphine in whole blood from suspected drug users. Forensic Sci Int 209:113\u2013119","journal-title":"Forensic Sci Int"},{"key":"1122_CR46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00414-010-0449-1","volume":"124","author":"A Pelissier-Alicot","year":"2010","unstructured":"Pelissier-Alicot A, Sastre C, Baillif-Couniou V, Gaulier J, Kintz P, Kuhlmann E, Perich P, Bartoli C, Piercecchi-Marti M, Leonetti G (2010) Buprenorphine-related deaths: unusual forensic situations. Int J Legal Med 124:647\u2013651","journal-title":"Int J Legal Med"},{"key":"1122_CR47","doi-asserted-by":"crossref","unstructured":"Larance B, Degenhardt L, O'Brien S, Lintzeris N, Winstock A, Mattick RP, Bell J, Ali R (2011) Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients. Drug Alcohol Rev. doi: 10.1111\/j.1465-3362.2010.00274.x","DOI":"10.1111\/j.1465-3362.2010.00274.x"},{"key":"1122_CR48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ADT.0b013e31817ea8b8","volume":"8","author":"PK Heikman","year":"2009","unstructured":"Heikman PK, Ojanper\u00e4 IA (2009) Inadequate dose of opioid-agonist medication is related to misuse of benzodiazepine. Addict Disord Their Treatment 8:145\u2013153","journal-title":"Addict Disord Their Treatment"},{"key":"1122_CR49","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1360-0443.2006.01731.x","volume":"102","author":"S Nielsen","year":"2007","unstructured":"Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D (2007) Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment. Addiction 102:616\u2013622","journal-title":"Addiction"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1122-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-011-1122-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1122-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:32:10Z","timestamp":1741696330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-011-1122-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,17]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1007\/s00228-011-1122-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,17]]}}}